Conway Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,765
| Closed | -$352K | – | 48 |
|
|
2023
Q1 | $352K | Sell |
9,765
-839
| -8% | -$30.2K | 0.29% | 33 |
|
|
2022
Q4 | $419K | Buy |
10,604
+10
| +0.1% | +$395 | 0.42% | 29 |
|
|
2022
Q3 | $426K | Sell |
10,594
-241
| -2% | -$9.68K | 0.38% | 31 |
|
|
2022
Q2 | $456K | Buy |
10,835
+10
| +0.1% | +$420 | 0.41% | 32 |
|
|
2022
Q1 | $422K | Buy |
+10,825
| New | +$422K | 0.27% | 38 |
|